Skip to main content
. Author manuscript; available in PMC: 2013 Jun 7.
Published in final edited form as: J Biomol Screen. 2013 Mar 7;18(5):621–628. doi: 10.1177/1087057113479971

Figure 4.

Figure 4

AlphaScreen assay development. A) Substrate titration revealed a strong increase in the AlphaScreen signal with concentrations above 8 nM with a maximum intensity at approximately 800 nM. B) Signal intensity was sharply lower in the presence of > 1 nM SENP2c. C) SENP2c-induced drop in signal intensity was prevented in the presence of > 40 µM NEM. D) Up to 5% DMSO did not interfere with the assay. All experiments were performed in triplicate and data are represented as mean±SD